XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Distributions in Excess of Accumulated Net Income
Accumulated Comprehensive Income (Loss)
Balance at the beginning (in shares) at Dec. 31, 2019   720,807,884      
Balance at the beginning, value at Dec. 31, 2019 $ 1,819,601 $ 721 $ 5,568,707 $ (3,750,884) $ 1,057
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (3,486)     (3,486)  
Unrealized gain (loss) on derivatives (14,141)       (14,141)
Reclassification to interest expense, net (145)       (145)
Distributions declared (13,678)     (13,678)  
Stock-based compensation, net 201   201    
Common stock issuance costs in excess of proceeds from distribution reinvestment plan (in shares)   21,249      
Common stock issuance costs in excess of proceeds from distribution reinvestment plan (229)   (229)    
Balance at the end (in shares) at Mar. 31, 2020   720,829,133      
Balance at the end, value at Mar. 31, 2020 1,788,123 $ 721 5,568,679 (3,768,048) (13,229)
Balance at the beginning (in shares) at Dec. 31, 2020   719,462,786      
Balance at the beginning, value at Dec. 31, 2020 1,738,863 $ 719 5,566,255 (3,815,662) (12,449)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (100)     (100)  
Unrealized gain (loss) on derivatives 1,893       1,893
Reclassification to interest expense, net 1,017       1,017
Reclassification to equity in earnings of unconsolidated entities 31       31
Distributions declared (14,065)     (14,065)  
Stock-based compensation, net 1,383   1,383    
Balance at the end (in shares) at Mar. 31, 2021   719,462,786      
Balance at the end, value at Mar. 31, 2021 $ 1,729,022 $ 719 $ 5,567,638 $ (3,829,827) $ (9,508)